MIST
NASDAQ · Pharmaceuticals
Milestone Pharmaceuticals In
$1.31
+0.01 (+0.77%)
Open$1.30
Previous Close$1.30
Day High$1.31
Day Low$1.27
52W High$3.06
52W Low$1.00
Volume—
Avg Volume1.41M
Market Cap161.85M
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+3,367.9% upside
Current
$1.31
$1.31
Target
$45.43
$45.43
$30.70
$45.43 avg
$53.70
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.26M | 3.34M | 19.07M |
| Net Income | -92,167,172 | -122,671,480 | 5.86M |
| Profit Margin | -4,078.8% | -3,874.8% | 30.7% |
| EBITDA | -90,659,049 | -127,367,785 | 12.52M |
| Free Cash Flow | — | — | 4.46M |
| Rev Growth | -32.4% | -32.4% | +19.4% |
| Debt/Equity | 1.37 | 1.37 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |